Rajesh Malik

Companies

• G1 Therapeutics, Inc.Chief Medical Officer May 16, 2017 to Sep 18, 2024¹
• POINT Biopharma Global Inc.Board member Jun 30, 2021 to Dec 27, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GTG1 Therapeutics, Inc.0 shares³Sep 18, 2024
• PBPOINT Biopharma Global Inc.0 shares⁴Dec 26, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 18, 2024U 87,450 shares of G1 Therapeutics, Inc.³
• Sep 18, 2024Returned to company 89,762 shares of G1 Therapeutics, Inc.³
• Sep 18, 2024Granted 17,900 shares of G1 Therapeutics, Inc.³
• Jul 5, 2024Sold 2,475 shares at $2.51 of G1 Therapeutics, Inc.⁵
• May 13, 2024Sold 8,151 shares at $4.79 of G1 Therapeutics, Inc.⁶
• Feb 12, 2024Sold 28,600 shares at $4.62 of G1 Therapeutics, Inc.⁷
• Feb 12, 2024Exercised options 28,600 shares at $0.30 of G1 Therapeutics, Inc.⁷
• Jan 4, 2024Sold 721 shares at $2.94 of G1 Therapeutics, Inc.⁸
• Jan 3, 2024Sold 2,261 shares at $3.12 of G1 Therapeutics, Inc.⁸
• Jan 3, 2024Sold 758 shares at $3.12 of G1 Therapeutics, Inc.⁸
• Jan 3, 2024Granted 37,300 shares of G1 Therapeutics, Inc.⁸
• Dec 26, 2023U 3,700 shares of POINT Biopharma Global Inc.⁴
• Dec 11, 2023Sold 12,400 shares at $4.02 of G1 Therapeutics, Inc.⁹
• Dec 11, 2023Exercised options 12,400 shares at $0.30 of G1 Therapeutics, Inc.⁹
• Dec 11, 2023Sold 21,439 shares at $3.06 of G1 Therapeutics, Inc.⁹
• Dec 11, 2023Exercised options 21,439 shares at $0.39 of G1 Therapeutics, Inc.⁹
• Jul 5, 2023Sold 1,361 shares at $2.45 of G1 Therapeutics, Inc.¹⁰
• May 10, 2023Granted 35,000 shares of G1 Therapeutics, Inc.¹¹
• Jan 5, 2023Sold 729 shares at $5.41 of G1 Therapeutics, Inc.¹²
• Jan 4, 2023Sold 1,639 shares at $5.58 of G1 Therapeutics, Inc.¹²
• Jan 3, 2023Granted 17,900 shares of G1 Therapeutics, Inc.¹²
• Dec 15, 2022Exercised options 14,000 shares at $0.30 of G1 Therapeutics, Inc.¹³
• Nov 28, 2022Bought 3,700 shares at $6.66 of POINT Biopharma Global Inc.¹⁴
• Sep 13, 2022Sold 18,000 shares at $15.71 of G1 Therapeutics, Inc.¹⁵
• Sep 13, 2022Exercised options 18,000 shares at $0.39 of G1 Therapeutics, Inc.¹⁵